跳至主要内容
临床试验/NCT01082744
NCT01082744已完成3 期

Thoracic Paravertebral Block: a Comparative Study of Ropivacaine With Ropivacaine and Sufentanil for Treating Pain After Video-assisted Thoracic Surgery.

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2010年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
90
试验地点
1
主要终点
morphine consumption during the first 48 hours

研究概览

简要总结

The use of paravertebral catheters is a recommended technique to achieve postoperative analgesia after thoracic surgery. To date there is no consensus on which drug regime (local anesthetics with or without opioid) is best. The aim of this prospective clinical trial is to determine wether the use of ropivacaine and sufentanil injected through a thoracic paravertebral catheter results in decreased acute postoperative pain compared with plain ropivacaine in patients after thoracoscopic lung surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient scheduled for planned video-assisted thoracic surgery
  • Patient that consent to participate
  • Planned placement of paravertebral catheter
  • Patient having a medical insurance

排除标准

  • Patient less than 18 years
  • Refusal to participate
  • Known pregnancy
  • Known allergies to local anesthetics, sufentanil and /or to iodinated contrast material
  • Intolerance to sufentanil and/or morphine
  • Chronic consumption of opiates
  • Preoperative chronic pain syndrome
  • Patient having a contraindication to placement of paravertebrtal catheter

研究组 & 干预措施

Continuous paravertebral block with ropivacaine

Active Comparator

干预措施: Ropivacaine (Drug)

Continuous paravertebral block with ropivacaine and sufentanil

Experimental

干预措施: Ropivacaine + Sufentanil (Drug)

结局指标

主要结局

morphine consumption during the first 48 hours

时间窗: 48 hours

次要结局

  • Acute pain(48 hours)
  • Biological measurements(48 hours)
  • Patient satisfaction(48 hours)
  • Chronic pain(3 and 6 monthes)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验